Treatment Options for Sleep Dysfunction in Parkinson's Disease

被引:0
|
作者
Thenganatt, Mary Ann
Frucht, Steven J. [1 ,2 ]
机构
[1] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10032 USA
[2] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
关键词
RESTLESS LEGS SYNDROME; EXCESSIVE DAYTIME SLEEPINESS; DOUBLE-BLIND; REM-SLEEP; BEHAVIOR DISORDER; EXOGENOUS MELATONIN; CONTROLLED-TRIAL; SYNDROME RLS; MODAFINIL; PRAMIPEXOLE;
D O I
10.1007/s11940-011-0139-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sleep disturbance is an important feature of Parkinson's disease (PD) that deserves clinical attention. Various disorders need to be considered and treatment should be customized to the patient's specific symptoms and lifestyle. Evaluation of a PD patient complaining of difficulty sleeping begins with a detailed history from the patient and bed partner about the specific problem the patient is experiencing. It is important to inquire about difficulties with sleep onset, frequent awakenings, increased movements during sleep, acting out dreams, uncomfortable motor symptoms, disordered breathing, and nocturia. Current medications should be reviewed to determine whether the recent addition of a drug or a change in dose may be contributing to sleep difficulties, and one should ask about daytime sleepiness, frequent daytime naps, and sleep hygiene in the evening that can contribute to problems sleeping at night. The goal of therapy is to restore quality nighttime sleep without excessive daytime sedation and to improve the patient's daily mental and physical function and overall quality of life.
引用
收藏
页码:473 / 487
页数:15
相关论文
共 50 条
  • [41] Laryngopharyngeal motor dysfunction and obstructive sleep apnea in Parkinson's disease
    Correa Silva Bahia, Christianne Martins
    Pereira, Joao Santos
    Lopes, Agnaldo Jose
    SLEEP AND BREATHING, 2019, 23 (02) : 543 - 550
  • [42] MOLECULAR IMAGING CORRELATES OF SLEEP DYSFUNCTION IN PARKINSON'S DISEASE (PD)
    Nene, D.
    Fu, J. F.
    Matarazzo, M.
    Sossi, V.
    Shahinfard, E.
    Vafai, N.
    McKenzie, J.
    Neilson, N.
    Miao, Q.
    Stoessl, A. J.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E13 - E13
  • [43] Laryngopharyngeal motor dysfunction and obstructive sleep apnea in Parkinson’s disease
    Christianne Martins Corrêa Silva Bahia
    João Santos Pereira
    Agnaldo José Lopes
    Sleep and Breathing, 2019, 23 : 543 - 550
  • [44] Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease
    Martinez-Martin, Pablo
    Rizos, Alexandra M.
    Wetmore, John B.
    Antonini, Angelo
    Odin, Per
    Pal, Suvankar
    Sophia, Rani
    Carroll, Camille
    Martino, Davide
    Falup-Pecurariu, Cristian
    Kessel, Belinda
    Andrews, Thomasin
    Paviour, Dominic
    Trenkwalder, Claudia
    Chaudhuri, Kallol Ray
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (01): : 57 - 64
  • [45] Melanopsin Cell Dysfunction is Involved in Sleep Disruption in Parkinson's Disease
    Feigl, Beatrix
    Dumpala, Sunila
    Kerr, Graham K.
    Zele, Andrew J.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1467 - 1476
  • [46] Parkinson’s disease: Surgical options
    Helen Bronte-Stewart
    Current Treatment Options in Neurology, 2003, 5 (2) : 131 - 147
  • [47] Surgical options in Parkinson's disease
    Arle, JE
    Alterman, RL
    MEDICAL CLINICS OF NORTH AMERICA, 1999, 83 (02) : 483 - +
  • [48] Therapeutic options for Parkinson's disease
    Shastry, BS
    DRUGS OF TODAY, 2002, 38 (06) : 445 - 451
  • [49] PARKINSON'S DISEASE: THERAPEUTIC OPTIONS
    Rampello, Luigi
    Vecchio, Ignazio
    Malaguarnera, Michele
    Battaglia, Giuseppe
    Rampello, Liborio
    ACTA MEDICA MEDITERRANEA, 2012, 28 (02): : 117 - 122
  • [50] Depression in patients with Parkinson's disease - Epidemiology, pathophysiology and treatment options
    Zesiewicz, TA
    Hauser, RA
    CNS DRUGS, 2000, 13 (04) : 253 - 264